Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoya Uchida

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Nature Communications|October 12, 2023
Fertility-preserving myeloablative conditioning using single-dose CD117 antibody-drug conjugate in a rhesus gene therapy modelNaoya Uchida, Ulana Stasula, Selami Demirci, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2019
Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus MacaqueDiego A Espinoza, Xing Fan, Di Yang, et al.
Clinical Endocrinology|December 14, 2020
Commentary on Winzeler et al 'Low arginine vasopressin levels in patients with diabetes insipidus are not associated with anaemia'Balázs Mayer, Krisztián Németh, Miklós Krepuska, et al.
Nature Medicine|March 19, 2021
Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cellsM Kyle Cromer, Joab Camarena, Renata M Martin, et al.
Scientific Reports|October 16, 2024
Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell diseaseSamuel Lessard, Pauline Rimmelé, Hui Ling, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2024
Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34<sup>+</sup> cell therapy to induce fetal hemoglobin for sickle cell diseaseVarun Katta, Kiera O'Keefe, Yichao Li, et al.
Science Translational Medicine|December 1, 2017
Vasopressin stimulates the proliferation and differentiation of red blood cell precursors and improves recovery from anemiaBalázs Mayer, Krisztián Németh, Miklós Krepuska, et al.
Molecular Therapy. Nucleic Acids|February 28, 2023
Forced enhancer-promoter rewiring to alter gene expression in animal modelsScott A Peslak, Selami Demirci, Vemika Chandra, et al.
Cell Reports Methods|May 9, 2023
Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cellsNaritaka Tamaoki, Stefan Siebert, Takuya Maeda, et al.
The Journal of Clinical Investigation|September 8, 2020
BCL11A enhancer-edited hematopoietic stem cells persist in rhesus monkeys without toxicitySelami Demirci, Jing Zeng, Yuxuan Wu, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Nature Communications|October 12, 2023
Fertility-preserving myeloablative conditioning using single-dose CD117 antibody-drug conjugate in a rhesus gene therapy modelNaoya Uchida, Ulana Stasula, Selami Demirci, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2019
Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus MacaqueDiego A Espinoza, Xing Fan, Di Yang, et al.
Clinical Endocrinology|December 14, 2020
Commentary on Winzeler et al 'Low arginine vasopressin levels in patients with diabetes insipidus are not associated with anaemia'Balázs Mayer, Krisztián Németh, Miklós Krepuska, et al.
Nature Medicine|March 19, 2021
Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cellsM Kyle Cromer, Joab Camarena, Renata M Martin, et al.
Scientific Reports|October 16, 2024
Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell diseaseSamuel Lessard, Pauline Rimmelé, Hui Ling, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2024
Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34<sup>+</sup> cell therapy to induce fetal hemoglobin for sickle cell diseaseVarun Katta, Kiera O'Keefe, Yichao Li, et al.
Science Translational Medicine|December 1, 2017
Vasopressin stimulates the proliferation and differentiation of red blood cell precursors and improves recovery from anemiaBalázs Mayer, Krisztián Németh, Miklós Krepuska, et al.
Molecular Therapy. Nucleic Acids|February 28, 2023
Forced enhancer-promoter rewiring to alter gene expression in animal modelsScott A Peslak, Selami Demirci, Vemika Chandra, et al.
Cell Reports Methods|May 9, 2023
Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cellsNaritaka Tamaoki, Stefan Siebert, Takuya Maeda, et al.
The Journal of Clinical Investigation|September 8, 2020
BCL11A enhancer-edited hematopoietic stem cells persist in rhesus monkeys without toxicitySelami Demirci, Jing Zeng, Yuxuan Wu, et al.
Pageof 9